FDA advisers recommend COVID boosters for 65 and older, reject broad approval | Reuters

By a vote of 16 to 2, members of the FDA’s Vaccines and Related Biological Products Advisory Committee declined to recommend a third dose of the Pfizer (PFE.N)/BioNTech vaccine to anyone age 16 and older who received their second shot at least six months earlier. Source: FDA advisers recommend COVID …

Read more

Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster market | Reuters

NEW YORK, Aug 13 (Reuters) – Drugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come, analysts and healthcare investors say. For several …

Read more